Model
Edge
Alnylam Pharmaceuticals, Inc.
0001438226
Filing Type
4
Filing Date
3/13/2025
Updated
3/14/25, 2:16 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership